Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

549 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biological response modifiers.
Clark JW. Clark JW. Cancer Chemother Biol Response Modif. 1996;16:239-73. Cancer Chemother Biol Response Modif. 1996. PMID: 8639384 Review. No abstract available.
Current perspectives on locally advanced pancreatic cancer.
Czito BG, Willett CG, Clark JW, Fernandez Del Castillo C. Czito BG, et al. Among authors: clark jw. Oncology (Williston Park). 2000 Nov;14(11):1535-45; discussion 1546, 1549-52. Oncology (Williston Park). 2000. PMID: 11125940 Review.
Biological response modifiers.
Clark JW. Clark JW. Cancer Chemother Biol Response Modif. 1999;18:223-38. Cancer Chemother Biol Response Modif. 1999. PMID: 10800485 Review. No abstract available.
Chemotherapy for soft tissue sarcomas.
Clark JW. Clark JW. Med Health R I. 1997 Jan;80(1):37-8. Med Health R I. 1997. PMID: 9009582 Review. No abstract available.
Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer.
Hezel AF, Noel MS, Allen JN, Abrams TA, Yurgelun M, Faris JE, Goyal L, Clark JW, Blaszkowsky LS, Murphy JE, Zheng H, Khorana AA, Connolly GC, Hyrien O, Baran A, Herr M, Ng K, Sheehan S, Harris DJ, Regan E, Borger DR, Iafrate AJ, Fuchs C, Ryan DP, Zhu AX. Hezel AF, et al. Among authors: clark jw. Br J Cancer. 2014 Jul 29;111(3):430-6. doi: 10.1038/bjc.2014.343. Epub 2014 Jun 24. Br J Cancer. 2014. PMID: 24960403 Free PMC article. Clinical Trial.
549 results